RISEDRONATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Risedronate, and when can generic versions of Risedronate launch?
Risedronate is a drug marketed by Impax Labs Inc, Sun Pharm, Teva Pharms Usa, Zydus Pharms, Apotex, Aurobindo Pharma, Aurobindo Pharma Ltd, Hangzhou Binjiang, Macleods Pharms Ltd, Orbion Pharms, and Pharmobedient. and is included in fourteen NDAs.
The generic ingredient in RISEDRONATE is risedronate sodium. There are nineteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the risedronate sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Risedronate
A generic version of RISEDRONATE was approved as risedronate sodium by TEVA PHARMS USA on October 5th, 2007.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for RISEDRONATE?
- What are the global sales for RISEDRONATE?
- What is Average Wholesale Price for RISEDRONATE?
Summary for RISEDRONATE
| US Patents: | 0 |
| Applicants: | 11 |
| NDAs: | 14 |
| Drug Prices: | Drug price information for RISEDRONATE |
| DailyMed Link: | RISEDRONATE at DailyMed |
US Patents and Regulatory Information for RISEDRONATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Pharms Usa | RISEDRONATE SODIUM | risedronate sodium | TABLET;ORAL | 077132-001 | Oct 5, 2007 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Teva Pharms Usa | RISEDRONATE SODIUM | risedronate sodium | TABLET;ORAL | 077132-002 | Oct 5, 2007 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Impax Labs Inc | RISEDRONATE SODIUM | risedronate sodium | TABLET, DELAYED RELEASE;ORAL | 205066-001 | Jun 29, 2018 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pharmobedient | RISEDRONATE SODIUM | risedronate sodium | TABLET;ORAL | 200477-001 | Nov 30, 2015 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
